Human Papillomavirus (HPV) in Ghana

Human Papillomavirus in Ghana
HPV Vaccine
The State of Human Papillomavirus in Ghana.ogg
Dominic Domenyo Gadeka,gives insights on the HPV medical condition.
Problems playing this file? See media help.

Human Papillomavirus in Ghana; each year about 3,000 Ghanaian women are diagnosed cervical cancer caused by Human Papillomavirus, HPV. It is estimated that 2,000 women die out of the 3000 annually.[1]

Cervical cancer is the second most common female cancer among women between the ages of age of 15 to 44 years and a high prevalence rate in Ghana compared to the Western Africa region.[2] 57.8% of Ghanaian women visiting the Korle -Bu Teaching Hospital with gynecological cancer had cervical cancer as well.[3]

According to the Global cancer observatory, cervical cancer is the third highest in cancers in 2020 and among female cancers, recording the second highest number of new cases after breast cancer in Ghana.[4] In an observation of 348 women diagnosed with cervical cancer, almost 60 per cent tested positive for HPV type 16 and 18 which is a causative factor of cervical cancer.

The increasing mortality among women with cervical cancer in Ghana suggests 26 in 100,000 Ghanaian women compared to women in most developed countries.[5][6] 13.9% of pregnant women sampled for a study in the Western Region of Ghana were considered at a high risk HPV positive.[7]

  1. ^ "Yemaachi partners The Mirror, Graphic Union ...for cervical cancer awareness". Graphic Online. Retrieved 2022-05-17.
  2. ^ Krings, Amrei; Dunyo, Priscilla; Pesic, Aleksandra; Tetteh, Saviour; Hansen, Benjamin; Gedzah, Isaac; Wormenor, Comfort M.; Amuah, Joseph E.; Behnke, Anna-Lisa; Höfler, Daniela; Pawlita, Michael (2019-06-27). Adebamowo, Clement A. (ed.). "Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana". PLOS ONE. 14 (6): e0218762. Bibcode:2019PLoSO..1418762K. doi:10.1371/journal.pone.0218762. ISSN 1932-6203. PMC 6597158. PMID 31246997.
  3. ^ Krings, Amrei; Dunyo, Priscilla; Pesic, Aleksandra; Tetteh, Saviour; Hansen, Benjamin; Gedzah, Isaac; Wormenor, Comfort M.; Amuah, Joseph E.; Behnke, Anna-Lisa; Höfler, Daniela; Pawlita, Michael (2019-06-27). Adebamowo, Clement A. (ed.). "Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana". PLOS ONE. 14 (6): e0218762. Bibcode:2019PLoSO..1418762K. doi:10.1371/journal.pone.0218762. ISSN 1932-6203. PMC 6597158. PMID 31246997.
  4. ^ "Time to tackle cervical cancer head-on". Graphic Online. Retrieved 2022-05-17.
  5. ^ "Time to tackle cervical cancer head-on". Graphic Online. Retrieved 2022-05-17.
  6. ^ Krings, Amrei; Dunyo, Priscilla; Pesic, Aleksandra; Tetteh, Saviour; Hansen, Benjamin; Gedzah, Isaac; Wormenor, Comfort M.; Amuah, Joseph E.; Behnke, Anna-Lisa; Höfler, Daniela; Pawlita, Michael (2019-06-27). Adebamowo, Clement A. (ed.). "Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana". PLOS ONE. 14 (6): e0218762. Bibcode:2019PLoSO..1418762K. doi:10.1371/journal.pone.0218762. ISSN 1932-6203. PMC 6597158. PMID 31246997.
  7. ^ Schulze, Marco H.; Völker, Fabian M.; Lugert, Raimond; Cooper, Paul; Hasenclever, Kai; Groß, Uwe; Pfister, Herbert; Silling, Steffi (2016-12-01). "High prevalence of human papillomaviruses in Ghanaian pregnant women". Medical Microbiology and Immunology. 205 (6): 595–602. doi:10.1007/s00430-016-0475-9. ISSN 1432-1831. PMID 27601062. S2CID 22628389.